Skip NavigationSkip to Content

What’s New at the ACL

The Antibody Characterization Laboratory (ACL) through its sponsoring office at NCI, CPTC, is able to interact with industry partners to aide in the development of antibodies. ¬†Recently, Gordon Whiteley (Director, ACL) was named as the Principal Investigator on a Cooperative Research and Development Agreement with Epitomics Inc. to characterize rabbit monoclonal antibodies through the ACL characterization pipeline. MORE…



Page last updated June 10, 2013 @ 8:06 am